tirzepatide court case FDA Says Compounded Must Exit the Market FDA facing blowback after ending

These rules make sure that compounded tirzepatide is made with the right active ingredient, using its base form

These channels typically provide higher quality assurance than research peptide vendors, though access is more restricted and costs may be higher

And most of those are for girls and young women, even as questions remain about the long-term impact of the medications, including on reproductive health

However, your health care provider might consider alternatives such as Wegovy, Mounjaro, or Saxenda, all of which are GLP-1 medications but not all are FDA-approved for weight loss specifically.

However, Ozempic and similar GLP-1 receptor agonists have been linked to severe gastrointestinal issues, including gastroparesis, or stomach paralysis